Prospective therapeutic targets and recent advancements in the treatment of inflammatory bowel disease

Abstract

Objective

Inflammatory Bowel Disease (IBD) poses a persistent challenge in the realm of gastroenterology, necessitating continual exploration of innovative treatment strategies. The limited efficacy and potential side effects associated with existing therapeutic modalities underscore the urgent need for novel approaches in IBD management. This study aims to examine potential therapeutic targets and recent advancements in understanding the disease’s intricate pathogenesis, with a spotlight on the gut microbiome, immune dysregulation, and genetic predispositions.

Methods

A comprehensive review was conducted to delve into the pressing demand for new avenues in IBD treatment. The study examined potential therapeutic targets such as phosphodiesterase 4 (PDE4) inhibitors, immune system modulators, Tyrosine kinase receptors (TYK), Toll-like receptors (TLRs), modulation of the gut microbiota, stem cell therapy, fibrosis management, interleukins (ILs) regulation, and oxidative stress mitigation. Additionally, advances in precision medicine, biologics, small molecule inhibitors, and microbiome modulation techniques were explored.

Results

The investigation unveiled promising therapeutic targets and provided insights into recent breakthroughs that herald a transformative era in the therapeutic landscape for IBD. Advances in precision medicine, biologics, small molecule inhibitors, and the exploration of microbiome modulation techniques stood out as pivotal milestones in the field of gastroenterology.

Conclusions

The findings offer renewed hope for enhanced efficacy, reduced side effects, and improved patient outcomes in the treatment of IBD. These innovative approaches necessitate continual exploration and underscore the urgent need for novel strategies in IBD management, potentially revolutionizing the realm of gastroenterology.

Keywords:

• Ulcerative colitis (UC)
• Crohn’s disease (CD)
• phosphodiesterase 4 inhibitor
• toll like receptor
• tyrosine kinase receptors
• Janus kinase receptor
• oxidative stress
• interleukins

Author contributions

SR, as supervisor, played a pivotal role in conceptualizing and designing the study, AS conducted an exhaustive literature review, and shaping the methodological framework and writing of manuscript. SR provided valuable insights, guidance, and oversight throughout the entire process. Together, AS and SR collaborated to ensure the depth and coherence of the manuscript. All authors reviewed and approved the manuscript.

Disclosure statement

No potential conflict of interest was reported by the author(s).